Methyl 4-(((1,1-dimethylethoxy)carbonyl)amino)-4-piperidinecarboxylate → {2-[4-(tert-Butoxycarbonylamino)-4-(methoxycarbonyl)piperidin-1-yl]pyrimidin-5-yl}-boronic acid
Reaktionsgleichung
[C:1]([O:5][C:6]([NH:8][C:9]1([C:15]([O:17][CH3:18])=[O:16])[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl[C:20]1[N:25]=[CH:24][C:23]([B:26]([OH:28])[OH:27])=[CH:22][N:21]=1>>[C:1]([O:5][C:6]([NH:8][C:9]1([C:15]([O:17][CH3:18])=[O:16])[CH2:14][CH2:13][N:12]([C:20]2[N:25]=[CH:24][C:23]([B:26]([OH:28])[OH:27])=[CH:22][N:21]=2)[CH2:11][CH2:10]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]Komponenten
3
Versuchsvorschrift
The title compound was synthesised from methyl 4-(tert-butoxycarbonylamino)-piperidine-4-carboxylate and (2-chloropyrimidin-5-yl)boronic acid in accordance with General Method C.
Quellen und Nachweise
- ORD-Eintrag
- ord-e87f36ca219b498786c36b99469d70c2
- Quelldatensatz
- uspto-grants-2016_04
- Patentnummer
- US09309243B2
Notizen zur Reaktion
Wird geladen…